Zura Bio Limited (94E.F)

EUR 0.98

(-7.55%)

EBITDA Summary of Zura Bio Limited

  • Zura Bio Limited's latest annual EBITDA in 2023 was -60.56 Million USD , N/A from previous year.
  • Zura Bio Limited's latest quarterly EBITDA in 2024 Q2 was -10.99 Million USD , down -40.34% from previous quarter.
  • Zura Bio Limited reported an annual EBITDA of -27.33 Million USD in 2022, down 0.0% from previous year.
  • Zura Bio Limited reported an annual EBITDA of 8.41 Million USD in 2021, N/A from previous year.
  • Zura Bio Limited reported a quarterly EBITDA of -7.77 Million USD for 2024 Q1, up 22.61% from previous quarter.
  • Zura Bio Limited reported a quarterly EBITDA of -11.29 Million USD for 2023 Q3, up 66.16% from previous quarter.

Annual EBITDA Chart of Zura Bio Limited (2023 - 2021)

Historical Annual EBITDA of Zura Bio Limited (2023 - 2021)

Year EBITDA EBITDA Growth
2023 -60.56 Million USD N/A
2022 -27.33 Million USD 0.0%
2021 8.41 Million USD N/A

Peer EBITDA Comparison of Zura Bio Limited

Name EBITDA EBITDA Difference
BioNTech SE 1.08 Billion EUR 105.568%
CureVac N.V. -234.09 Million EUR 74.128%
Biotest Aktiengesellschaft 179 Million EUR 133.834%
Biotest Aktiengesellschaft 179 Million EUR 133.834%
BRAIN Biotech AG -2.38 Million EUR -2437.202%
Formycon AG 81.05 Million EUR 174.72%
Heidelberg Pharma AG -18.7 Million EUR -223.756%
Medigene AG -14.58 Million EUR -315.242%